# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-043893
Filing Date
2024-11-07
Accepted
2024-11-07 06:09:10
Documents
69
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1653925
2 |  | ex31-1.htm | EX-31.1 | 16023
3 |  | ex31-2.htm | EX-31.2 | 16460
4 |  | ex32-1.htm | EX-32.1 | 5359
5 |  | ex32-2.htm | EX-32.2 | 5609
6 |  | form10-q_chart.jpg | GRAPHIC | 129217
| Complete submission text file | 0001493152-24-043893.txt |  | 7316807

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | lpcn-20240930.xsd | EX-101.SCH | 38205
8 | XBRL CALCULATION FILE | lpcn-20240930_cal.xml | EX-101.CAL | 46218
9 | XBRL DEFINITION FILE | lpcn-20240930_def.xml | EX-101.DEF | 195514
10 | XBRL LABEL FILE | lpcn-20240930_lab.xml | EX-101.LAB | 374387
11 | XBRL PRESENTATION FILE | lpcn-20240930_pre.xml | EX-101.PRE | 315163
72 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1222722

Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36357 | Film No.: 241432911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)